A Pilot Study to Evaluate the Effects of Imiquimod and Tumor Lysate Vaccine Immunotherapy for Adults With High Risk or Recurrent/Post-Chemotherapy WHO Grade II Gliomas
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Brain tumour initiating cell vaccine (Primary) ; Imiquimod (Primary)
- Indications Astrocytoma; Glioma
- Focus Adverse reactions; Pharmacodynamics
- 21 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2019.
- 21 Nov 2017 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2017.
- 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.